Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network
- 1 September 1993
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 93 (Supplement) , 14-15
- https://doi.org/10.1111/j.1365-2249.1993.tb06218.x
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Selectivity of Recognition of Variable (V) Regions of Autoantibodies by Intravenous Immunoglobulin (IVIg)Clinical Immunology and Immunopathology, 1994
- Expression and control of the natural autoreactive IgG repertoire in normal human serumEuropean Journal of Immunology, 1993
- Intravenous Immunoglobulin Therapy of Autoimmune and Systemic Inflammatory DiseasesVox Sanguinis, 1993
- A V region‐connected autoreactive subfraction of normal human serum immunoglobulin GEuropean Journal of Immunology, 1992
- Population dynamics of natural antibodies in normal and autoimmune individuals.Proceedings of the National Academy of Sciences, 1991
- Treatment of systemic vasculitis with pooled intravenous immunoglobulinThe Lancet, 1991
- On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathyJournal of Neuroimmunology, 1990
- Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.Journal of Clinical Investigation, 1990
- Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.Proceedings of the National Academy of Sciences, 1987
- ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULINThe Lancet, 1984